Medical Condition News

RSS

Stroke warning signs need more urgent attention

Patients who suffer stroke-like attacks can have mortality rates 20 per cent higher than the general population, new research finds, leading to calls for better stroke prevention strategies for those who experience a transient ischemic attack (TIA).

10 Nov 2011

APMA encourages 'Knock Your Socks Off' foot care campaign for people with diabetes

American Podiatric Medical Association Encourages Hispanic Health Awareness with "Knock Your Socks Off" Foot Care Campaign, Promotes Regular Foot Exams by Podiatrist to End Diabetes Complications

10 Nov 2011

ArQule, Daiichi Sankyo enter license agreement for development of new AKT inhibitor

ArQule, Inc. and Daiichi Sankyo, Co. Ltd. announced today the execution of a license agreement for the development of a new AKT inhibitor called ARQ 092, the first compound to emerge from the companies' November 2008 agreement to collaborate on research utilizing the AKIP (ArQule Kinase Inhibitor Platform) technology to generate novel, selective and potent small molecule kinase inhibitors.

10 Nov 2011

New studies could fundamentally change medical treatment of liver cancer

Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan.

10 Nov 2011

Positive results from BIOTRONIK Pantera Lux Paclitaxel Releasing Balloon study presented at TCT 2011

Six-month results from the DELUX registry and 12-month results from the PEPPER study, both demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon, were presented on Tuesday and Wednesday at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference by Dr. Ralph Toelg, MD, Segeberger Heart Center Clinic, Bad Segeberg, Germany, and Prof. Christoph Hehrlein, MD, University Medical Center, Freiburg, Germany, respectively.

10 Nov 2011

FDA clears IDEV 6Fr SUPERA VERITAS Transhepatic Biliary Stent System

IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.

10 Nov 2011

ZOLL to display resuscitation technology, temperature management solutions at AHA 2011

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that 27 scientific presentations related to ZOLL products and technology are scheduled to be presented during the American Heart Association (AHA) 2011 Resuscitation Science Symposium (ReSS) and Scientific Sessions.

10 Nov 2011

eButton combines the powers of cameras, GPS, and other sensors to combat obesity

People attempting to lose weight won't need to track their daily food intake anymore, thanks to a wearable, picture-taking device created at the University of Pittsburgh. eButton -- a device worn on the chest (like a pin) that contains a miniature camera, accelerometer, GPS, and other sensors -- captures data and information of health activities, eliminating the need for daily self-reporting.

10 Nov 2011

Accumetrics VerifyNow test shows patients with high PRU exhibit higher stent thrombosis

Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that patients with high platelet reactivity, i.e. high PRU values as measured by the Accumetrics VerifyNow P2Y12 Test, exhibited an approximately four times higher rate of stent thrombosis than patients without high platelet reactivity, as seen in the ADAPT-DES registry.

10 Nov 2011

CCCBD scientist to receive 2011 V Foundation Translational Research Grant

Scientists at the Children's Center for Cancer and Blood Diseases (CCCBD) and the Keck School of Medicine of the University of Southern California, have been awarded a highly competitive translational research grant of $600,000 from The V Foundation for Cancer Research.

10 Nov 2011

Maxygen's MAXY-G34 for Acute Radiation Syndrome not considered for BARDA award

Maxygen, Inc. today announced that it has been advised by the Biomedical Advanced Research and Development Authority (BARDA) that Maxygen's proposal for the development of its MAXY-G34 product candidate as a potential medical countermeasure for Acute Radiation Syndrome (ARS) will not be considered for a contract award.

10 Nov 2011

'Social Norms and Alcohol Prevention' to address problem drinking in college students

Perceptions of peer drinking of alcohol may be the strongest predictor of excessive alcohol use among college students according to new research by Clayton Neighbors, a professor and director of the social psychology program in the department of psychology at the University of Houston.

10 Nov 2011

Inadequate car seat support may trigger back pain

Inadequate car seat support may be responsible for triggering back pain, reports Edmunds.com, the premier online resource for automotive information. And while there are improvised ways to ease and prevent back discomfort - like purchasing an inflatable pillow or moldable seat supports - most new cars now offer technically advanced lumbar support adjustments.

10 Nov 2011

Rensselaer engineer receives $1.4M NIH grant to study new method to heal traumatic nerve damage

Injuries to the nervous system affect large numbers of people globally. Such injuries can result in loss of feeling or movement. With a new $1.4 million grant from the National Institutes of Health, Deanna Thompson, associate professor of biomedical engineering at Rensselaer Polytechnic Institute, will investigate a promising new method to heal traumatic nerve damage, using electrical stimulation to prime and pump neuronal growth.

10 Nov 2011

Experimental drug selectively destroys blood supply of fat tissue and decreases body fat

Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.

10 Nov 2011

Positive results from Alkermes VIVITROL addiction study

Alkermes plc today presented positive results from a long-term study of VIVITROL (naltrexone for extended-release injectable suspension) at the 24th Annual U.S. Psychiatric and Mental Health Congress in Las Vegas, NV.

10 Nov 2011

Tailored anti-platelet therapy optimizes treatment for patients wtih common genetic variant

Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.

10 Nov 2011

New cellular targets for devastating neurological disorder

In a paper published in the November 9 issue of The Journal of Neuroscience, researchers at the University of California, San Diego School of Medicine and University of Washington describe in deeper detail the pathology of a devastating neurological disorder, but also reveal new cellular targets for possibly slowing its development.

10 Nov 2011

Clinical diagnoses of autism may vary widely across centers

To diagnose autism spectrum disorders, clinicians typically administer a variety of tests or scales and use information from observations and parent interviews to classify individuals into subcategories listed in standard psychiatric diagnostic manuals.

10 Nov 2011

Combination of azacitidine and entinostat shows promise against NSCLC

A new type of therapy aimed at reversing the gene-silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center.

10 Nov 2011

Medical Condition News

Stroke warning signs need more urgent attention

APMA encourages 'Knock Your Socks Off' foot care campaign for people with diabetes

ArQule, Daiichi Sankyo enter license agreement for development of new AKT inhibitor

New studies could fundamentally change medical treatment of liver cancer

Positive results from BIOTRONIK Pantera Lux Paclitaxel Releasing Balloon study presented at TCT 2011

FDA clears IDEV 6Fr SUPERA VERITAS Transhepatic Biliary Stent System

ZOLL to display resuscitation technology, temperature management solutions at AHA 2011

eButton combines the powers of cameras, GPS, and other sensors to combat obesity

Accumetrics VerifyNow test shows patients with high PRU exhibit higher stent thrombosis

CCCBD scientist to receive 2011 V Foundation Translational Research Grant

Maxygen's MAXY-G34 for Acute Radiation Syndrome not considered for BARDA award

'Social Norms and Alcohol Prevention' to address problem drinking in college students

Inadequate car seat support may trigger back pain

Rensselaer engineer receives $1.4M NIH grant to study new method to heal traumatic nerve damage

Experimental drug selectively destroys blood supply of fat tissue and decreases body fat

Positive results from Alkermes VIVITROL addiction study

Tailored anti-platelet therapy optimizes treatment for patients wtih common genetic variant

New cellular targets for devastating neurological disorder

Clinical diagnoses of autism may vary widely across centers

Combination of azacitidine and entinostat shows promise against NSCLC

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News